nodes	percent_of_prediction	percent_of_DWPC	metapath
Methocarbamol—Felbamate—epilepsy syndrome	0.477	1	CrCtD
Methocarbamol—Felbamate—Lacosamide—epilepsy syndrome	0.196	1	CrCrCtD
Methocarbamol—CA1—Lacosamide—epilepsy syndrome	0.0847	0.359	CbGbCtD
Methocarbamol—CA1—Acetazolamide—epilepsy syndrome	0.0583	0.247	CbGbCtD
Methocarbamol—CA1—Zonisamide—epilepsy syndrome	0.054	0.228	CbGbCtD
Methocarbamol—CA1—Topiramate—epilepsy syndrome	0.0393	0.166	CbGbCtD
Methocarbamol—CA1—Reversible hydration of carbon dioxide—CA13—epilepsy syndrome	0.00456	0.282	CbGpPWpGaD
Methocarbamol—CA1—Erythrocytes take up carbon dioxide and release oxygen—CA4—epilepsy syndrome	0.0037	0.229	CbGpPWpGaD
Methocarbamol—CA1—Reversible hydration of carbon dioxide—CA4—epilepsy syndrome	0.00294	0.182	CbGpPWpGaD
Methocarbamol—CA1—Erythrocytes take up carbon dioxide and release oxygen—AQP1—epilepsy syndrome	0.002	0.124	CbGpPWpGaD
Methocarbamol—Ranolazine—SCN9A—epilepsy syndrome	0.000483	0.248	CrCbGaD
Methocarbamol—Felbamate—GRIN2A—epilepsy syndrome	0.000438	0.226	CrCbGaD
Methocarbamol—Felbamate—GRIN2B—epilepsy syndrome	0.000373	0.192	CrCbGaD
Methocarbamol—CA1—C-MYB transcription factor network—CASP6—epilepsy syndrome	0.000317	0.0196	CbGpPWpGaD
Methocarbamol—CA1—C-MYB transcription factor network—HES1—epilepsy syndrome	0.00015	0.00931	CbGpPWpGaD
Methocarbamol—Felbamate—CYP2C19—epilepsy syndrome	0.000125	0.0642	CrCbGaD
Methocarbamol—Carvedilol—VEGFA—epilepsy syndrome	0.000104	0.0533	CrCbGaD
Methocarbamol—CA1—Metabolism—CA13—epilepsy syndrome	9.26e-05	0.00574	CbGpPWpGaD
Methocarbamol—CA1—C-MYB transcription factor network—BCL2—epilepsy syndrome	8.86e-05	0.00549	CbGpPWpGaD
Methocarbamol—CA1—C-MYB transcription factor network—PTGS2—epilepsy syndrome	8.42e-05	0.00522	CbGpPWpGaD
Methocarbamol—Ranolazine—CYP2D6—epilepsy syndrome	7.55e-05	0.0388	CrCbGaD
Methocarbamol—Somnolence—Phenytoin—epilepsy syndrome	7.07e-05	0.000975	CcSEcCtD
Methocarbamol—Hypersensitivity—Midazolam—epilepsy syndrome	7.06e-05	0.000974	CcSEcCtD
Methocarbamol—Dyspepsia—Clonazepam—epilepsy syndrome	7.05e-05	0.000972	CcSEcCtD
Methocarbamol—Body temperature increased—Vigabatrin—epilepsy syndrome	7.04e-05	0.000971	CcSEcCtD
Methocarbamol—Somnolence—Oxcarbazepine—epilepsy syndrome	7.03e-05	0.00097	CcSEcCtD
Methocarbamol—Nausea—Clobazam—epilepsy syndrome	7.03e-05	0.00097	CcSEcCtD
Methocarbamol—CA1—Metabolism—FAR1—epilepsy syndrome	7.02e-05	0.00435	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—CERS1—epilepsy syndrome	7.02e-05	0.00435	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—ADK—epilepsy syndrome	7.02e-05	0.00435	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—GLUD1—epilepsy syndrome	7.02e-05	0.00435	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—L2HGDH—epilepsy syndrome	7.02e-05	0.00435	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—PDXK—epilepsy syndrome	7.02e-05	0.00435	CbGpPWpGaD
Methocarbamol—Dyspepsia—Phenytoin—epilepsy syndrome	7e-05	0.000966	CcSEcCtD
Methocarbamol—Dysgeusia—Valproic Acid—epilepsy syndrome	6.99e-05	0.000965	CcSEcCtD
Methocarbamol—Feeling abnormal—Felbamate—epilepsy syndrome	6.99e-05	0.000965	CcSEcCtD
Methocarbamol—Dizziness—Acetazolamide—epilepsy syndrome	6.98e-05	0.000962	CcSEcCtD
Methocarbamol—Hypersensitivity—Levetiracetam—epilepsy syndrome	6.97e-05	0.000962	CcSEcCtD
Methocarbamol—Urticaria—Diazepam—epilepsy syndrome	6.97e-05	0.000961	CcSEcCtD
Methocarbamol—Dyspepsia—Oxcarbazepine—epilepsy syndrome	6.96e-05	0.00096	CcSEcCtD
Methocarbamol—Carvedilol—ADRA2A—epilepsy syndrome	6.94e-05	0.0357	CrCbGaD
Methocarbamol—Pruritus—Propofol—epilepsy syndrome	6.93e-05	0.000956	CcSEcCtD
Methocarbamol—Bradycardia—Gabapentin—epilepsy syndrome	6.92e-05	0.000955	CcSEcCtD
Methocarbamol—Flushing—Pregabalin—epilepsy syndrome	6.88e-05	0.00095	CcSEcCtD
Methocarbamol—Insomnia—Carbamazepine—epilepsy syndrome	6.87e-05	0.000947	CcSEcCtD
Methocarbamol—Pain—Clonazepam—epilepsy syndrome	6.85e-05	0.000944	CcSEcCtD
Methocarbamol—Feeling abnormal—Zonisamide—epilepsy syndrome	6.85e-05	0.000944	CcSEcCtD
Methocarbamol—Pruritus—Midazolam—epilepsy syndrome	6.78e-05	0.000936	CcSEcCtD
Methocarbamol—Pain—Oxcarbazepine—epilepsy syndrome	6.76e-05	0.000933	CcSEcCtD
Methocarbamol—Somnolence—Carbamazepine—epilepsy syndrome	6.75e-05	0.000931	CcSEcCtD
Methocarbamol—Urticaria—Felbamate—epilepsy syndrome	6.74e-05	0.00093	CcSEcCtD
Methocarbamol—Vision blurred—Valproic Acid—epilepsy syndrome	6.73e-05	0.000929	CcSEcCtD
Methocarbamol—Body temperature increased—Felbamate—epilepsy syndrome	6.71e-05	0.000925	CcSEcCtD
Methocarbamol—Vomiting—Acetazolamide—epilepsy syndrome	6.71e-05	0.000925	CcSEcCtD
Methocarbamol—Pruritus—Levetiracetam—epilepsy syndrome	6.7e-05	0.000924	CcSEcCtD
Methocarbamol—Dyspepsia—Carbamazepine—epilepsy syndrome	6.68e-05	0.000922	CcSEcCtD
Methocarbamol—Insomnia—Lamotrigine—epilepsy syndrome	6.64e-05	0.000915	CcSEcCtD
Methocarbamol—Headache—Acetazolamide—epilepsy syndrome	6.61e-05	0.000912	CcSEcCtD
Methocarbamol—Urticaria—Zonisamide—epilepsy syndrome	6.6e-05	0.00091	CcSEcCtD
Methocarbamol—Feeling abnormal—Clonazepam—epilepsy syndrome	6.6e-05	0.00091	CcSEcCtD
Methocarbamol—Oxprenolol—CYP2D6—epilepsy syndrome	6.6e-05	0.0339	CrCbGaD
Methocarbamol—Body temperature increased—Zonisamide—epilepsy syndrome	6.57e-05	0.000906	CcSEcCtD
Methocarbamol—Hypersensitivity—Vigabatrin—epilepsy syndrome	6.56e-05	0.000905	CcSEcCtD
Methocarbamol—Feeling abnormal—Phenytoin—epilepsy syndrome	6.55e-05	0.000904	CcSEcCtD
Methocarbamol—Angioedema—Valproic Acid—epilepsy syndrome	6.53e-05	0.0009	CcSEcCtD
Methocarbamol—Somnolence—Lamotrigine—epilepsy syndrome	6.52e-05	0.0009	CcSEcCtD
Methocarbamol—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	6.52e-05	0.000899	CcSEcCtD
Methocarbamol—Pain—Carbamazepine—epilepsy syndrome	6.49e-05	0.000895	CcSEcCtD
Methocarbamol—Dizziness—Propofol—epilepsy syndrome	6.48e-05	0.000894	CcSEcCtD
Methocarbamol—Pruritus—Fosphenytoin—epilepsy syndrome	6.46e-05	0.000892	CcSEcCtD
Methocarbamol—Hypersensitivity—Diazepam—epilepsy syndrome	6.46e-05	0.000891	CcSEcCtD
Methocarbamol—Dyspepsia—Lamotrigine—epilepsy syndrome	6.46e-05	0.000891	CcSEcCtD
Methocarbamol—CA1—Metabolism—GAMT—epilepsy syndrome	6.42e-05	0.00398	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—PNPO—epilepsy syndrome	6.42e-05	0.00398	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—EPM2A—epilepsy syndrome	6.42e-05	0.00398	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—NHLRC1—epilepsy syndrome	6.42e-05	0.00398	CbGpPWpGaD
Methocarbamol—Vertigo—Valproic Acid—epilepsy syndrome	6.42e-05	0.000885	CcSEcCtD
Methocarbamol—Leukopenia—Valproic Acid—epilepsy syndrome	6.39e-05	0.000882	CcSEcCtD
Methocarbamol—Urticaria—Clonazepam—epilepsy syndrome	6.36e-05	0.000877	CcSEcCtD
Methocarbamol—Dizziness—Midazolam—epilepsy syndrome	6.34e-05	0.000874	CcSEcCtD
Methocarbamol—Body temperature increased—Clonazepam—epilepsy syndrome	6.33e-05	0.000873	CcSEcCtD
Methocarbamol—Dysgeusia—Pregabalin—epilepsy syndrome	6.32e-05	0.000872	CcSEcCtD
Methocarbamol—Urticaria—Phenytoin—epilepsy syndrome	6.32e-05	0.000871	CcSEcCtD
Methocarbamol—Pruritus—Vigabatrin—epilepsy syndrome	6.3e-05	0.000869	CcSEcCtD
Methocarbamol—Body temperature increased—Phenytoin—epilepsy syndrome	6.29e-05	0.000867	CcSEcCtD
Methocarbamol—Urticaria—Oxcarbazepine—epilepsy syndrome	6.28e-05	0.000867	CcSEcCtD
Methocarbamol—Pain—Lamotrigine—epilepsy syndrome	6.27e-05	0.000865	CcSEcCtD
Methocarbamol—Nausea—Acetazolamide—epilepsy syndrome	6.27e-05	0.000864	CcSEcCtD
Methocarbamol—Dizziness—Levetiracetam—epilepsy syndrome	6.26e-05	0.000864	CcSEcCtD
Methocarbamol—Feeling abnormal—Carbamazepine—epilepsy syndrome	6.26e-05	0.000863	CcSEcCtD
Methocarbamol—Body temperature increased—Oxcarbazepine—epilepsy syndrome	6.25e-05	0.000863	CcSEcCtD
Methocarbamol—Vomiting—Propofol—epilepsy syndrome	6.23e-05	0.000859	CcSEcCtD
Methocarbamol—Pruritus—Diazepam—epilepsy syndrome	6.2e-05	0.000856	CcSEcCtD
Methocarbamol—Conjunctivitis—Topiramate—epilepsy syndrome	6.2e-05	0.000855	CcSEcCtD
Methocarbamol—Rash—Propofol—epilepsy syndrome	6.18e-05	0.000852	CcSEcCtD
Methocarbamol—Dermatitis—Propofol—epilepsy syndrome	6.17e-05	0.000851	CcSEcCtD
Methocarbamol—Headache—Propofol—epilepsy syndrome	6.14e-05	0.000847	CcSEcCtD
Methocarbamol—Hypersensitivity—Zonisamide—epilepsy syndrome	6.12e-05	0.000844	CcSEcCtD
Methocarbamol—Vomiting—Midazolam—epilepsy syndrome	6.1e-05	0.000841	CcSEcCtD
Methocarbamol—Vision blurred—Pregabalin—epilepsy syndrome	6.09e-05	0.000839	CcSEcCtD
Methocarbamol—Feeling abnormal—Lamotrigine—epilepsy syndrome	6.05e-05	0.000834	CcSEcCtD
Methocarbamol—Rash—Midazolam—epilepsy syndrome	6.04e-05	0.000834	CcSEcCtD
Methocarbamol—Dizziness—Fosphenytoin—epilepsy syndrome	6.04e-05	0.000833	CcSEcCtD
Methocarbamol—Dermatitis—Midazolam—epilepsy syndrome	6.04e-05	0.000833	CcSEcCtD
Methocarbamol—Alprenolol—CYP2D6—epilepsy syndrome	6.03e-05	0.031	CrCbGaD
Methocarbamol—Urticaria—Carbamazepine—epilepsy syndrome	6.03e-05	0.000832	CcSEcCtD
Methocarbamol—Vomiting—Levetiracetam—epilepsy syndrome	6.02e-05	0.00083	CcSEcCtD
Methocarbamol—Headache—Midazolam—epilepsy syndrome	6.01e-05	0.000828	CcSEcCtD
Methocarbamol—Pruritus—Felbamate—epilepsy syndrome	6e-05	0.000828	CcSEcCtD
Methocarbamol—Body temperature increased—Carbamazepine—epilepsy syndrome	6e-05	0.000828	CcSEcCtD
Methocarbamol—Rash—Levetiracetam—epilepsy syndrome	5.97e-05	0.000823	CcSEcCtD
Methocarbamol—CA1—Metabolism—CA4—epilepsy syndrome	5.97e-05	0.0037	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—QDPR—epilepsy syndrome	5.97e-05	0.0037	CbGpPWpGaD
Methocarbamol—Dermatitis—Levetiracetam—epilepsy syndrome	5.96e-05	0.000823	CcSEcCtD
Methocarbamol—Headache—Levetiracetam—epilepsy syndrome	5.93e-05	0.000818	CcSEcCtD
Methocarbamol—Angioedema—Pregabalin—epilepsy syndrome	5.9e-05	0.000814	CcSEcCtD
Methocarbamol—Hypersensitivity—Clonazepam—epilepsy syndrome	5.9e-05	0.000814	CcSEcCtD
Methocarbamol—Dizziness—Vigabatrin—epilepsy syndrome	5.89e-05	0.000812	CcSEcCtD
Methocarbamol—Confusional state—Valproic Acid—epilepsy syndrome	5.88e-05	0.000811	CcSEcCtD
Methocarbamol—Pruritus—Zonisamide—epilepsy syndrome	5.88e-05	0.000811	CcSEcCtD
Methocarbamol—Hypersensitivity—Phenytoin—epilepsy syndrome	5.86e-05	0.000808	CcSEcCtD
Methocarbamol—Anaphylactic shock—Valproic Acid—epilepsy syndrome	5.83e-05	0.000804	CcSEcCtD
Methocarbamol—Urticaria—Lamotrigine—epilepsy syndrome	5.83e-05	0.000804	CcSEcCtD
Methocarbamol—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	5.83e-05	0.000804	CcSEcCtD
Methocarbamol—Bradycardia—Topiramate—epilepsy syndrome	5.83e-05	0.000804	CcSEcCtD
Methocarbamol—Nausea—Propofol—epilepsy syndrome	5.82e-05	0.000803	CcSEcCtD
Methocarbamol—Vomiting—Fosphenytoin—epilepsy syndrome	5.81e-05	0.000801	CcSEcCtD
Methocarbamol—Vertigo—Pregabalin—epilepsy syndrome	5.8e-05	0.0008	CcSEcCtD
Methocarbamol—Body temperature increased—Lamotrigine—epilepsy syndrome	5.8e-05	0.0008	CcSEcCtD
Methocarbamol—Dysgeusia—Gabapentin—epilepsy syndrome	5.8e-05	0.0008	CcSEcCtD
Methocarbamol—Dizziness—Diazepam—epilepsy syndrome	5.8e-05	0.0008	CcSEcCtD
Methocarbamol—Syncope—Pregabalin—epilepsy syndrome	5.79e-05	0.000799	CcSEcCtD
Methocarbamol—Leukopenia—Pregabalin—epilepsy syndrome	5.78e-05	0.000797	CcSEcCtD
Methocarbamol—Rash—Fosphenytoin—epilepsy syndrome	5.76e-05	0.000795	CcSEcCtD
Methocarbamol—Dermatitis—Fosphenytoin—epilepsy syndrome	5.76e-05	0.000794	CcSEcCtD
Methocarbamol—Headache—Fosphenytoin—epilepsy syndrome	5.72e-05	0.00079	CcSEcCtD
Methocarbamol—Nausea—Midazolam—epilepsy syndrome	5.69e-05	0.000785	CcSEcCtD
Methocarbamol—Loss of consciousness—Pregabalin—epilepsy syndrome	5.68e-05	0.000783	CcSEcCtD
Methocarbamol—Pruritus—Clonazepam—epilepsy syndrome	5.66e-05	0.000781	CcSEcCtD
Methocarbamol—Vomiting—Vigabatrin—epilepsy syndrome	5.66e-05	0.000781	CcSEcCtD
Methocarbamol—Pruritus—Phenytoin—epilepsy syndrome	5.63e-05	0.000776	CcSEcCtD
Methocarbamol—Nausea—Levetiracetam—epilepsy syndrome	5.62e-05	0.000776	CcSEcCtD
Methocarbamol—Rash—Vigabatrin—epilepsy syndrome	5.62e-05	0.000775	CcSEcCtD
Methocarbamol—Dizziness—Felbamate—epilepsy syndrome	5.61e-05	0.000774	CcSEcCtD
Methocarbamol—CA1—Metabolism—COX3—epilepsy syndrome	5.61e-05	0.00348	CbGpPWpGaD
Methocarbamol—Dermatitis—Vigabatrin—epilepsy syndrome	5.61e-05	0.000774	CcSEcCtD
Methocarbamol—Pruritus—Oxcarbazepine—epilepsy syndrome	5.6e-05	0.000772	CcSEcCtD
Methocarbamol—Convulsion—Pregabalin—epilepsy syndrome	5.59e-05	0.000772	CcSEcCtD
Methocarbamol—Hypersensitivity—Carbamazepine—epilepsy syndrome	5.59e-05	0.000771	CcSEcCtD
Methocarbamol—Vision blurred—Gabapentin—epilepsy syndrome	5.58e-05	0.00077	CcSEcCtD
Methocarbamol—Headache—Vigabatrin—epilepsy syndrome	5.58e-05	0.00077	CcSEcCtD
Methocarbamol—Vomiting—Diazepam—epilepsy syndrome	5.57e-05	0.000769	CcSEcCtD
Methocarbamol—Rash—Diazepam—epilepsy syndrome	5.53e-05	0.000763	CcSEcCtD
Methocarbamol—Dermatitis—Diazepam—epilepsy syndrome	5.52e-05	0.000762	CcSEcCtD
Methocarbamol—Dizziness—Zonisamide—epilepsy syndrome	5.49e-05	0.000758	CcSEcCtD
Methocarbamol—Headache—Diazepam—epilepsy syndrome	5.49e-05	0.000758	CcSEcCtD
Methocarbamol—Hypotension—Valproic Acid—epilepsy syndrome	5.45e-05	0.000751	CcSEcCtD
Methocarbamol—Nausea—Fosphenytoin—epilepsy syndrome	5.43e-05	0.000749	CcSEcCtD
Methocarbamol—Angioedema—Gabapentin—epilepsy syndrome	5.41e-05	0.000746	CcSEcCtD
Methocarbamol—Hypersensitivity—Lamotrigine—epilepsy syndrome	5.4e-05	0.000746	CcSEcCtD
Methocarbamol—Vomiting—Felbamate—epilepsy syndrome	5.4e-05	0.000744	CcSEcCtD
Methocarbamol—Pruritus—Carbamazepine—epilepsy syndrome	5.37e-05	0.000741	CcSEcCtD
Methocarbamol—Rash—Felbamate—epilepsy syndrome	5.35e-05	0.000738	CcSEcCtD
Methocarbamol—Dermatitis—Felbamate—epilepsy syndrome	5.35e-05	0.000737	CcSEcCtD
Methocarbamol—Vertigo—Gabapentin—epilepsy syndrome	5.32e-05	0.000734	CcSEcCtD
Methocarbamol—CA1—Metabolism—SLCO1A2—epilepsy syndrome	5.32e-05	0.0033	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—PFKL—epilepsy syndrome	5.32e-05	0.0033	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—SLC6A8—epilepsy syndrome	5.32e-05	0.0033	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—CACNA2D2—epilepsy syndrome	5.32e-05	0.0033	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—KCNB1—epilepsy syndrome	5.32e-05	0.0033	CbGpPWpGaD
Methocarbamol—Headache—Felbamate—epilepsy syndrome	5.32e-05	0.000733	CcSEcCtD
Methocarbamol—Confusional state—Pregabalin—epilepsy syndrome	5.31e-05	0.000733	CcSEcCtD
Methocarbamol—Flushing—Topiramate—epilepsy syndrome	5.31e-05	0.000733	CcSEcCtD
Methocarbamol—Syncope—Gabapentin—epilepsy syndrome	5.31e-05	0.000732	CcSEcCtD
Methocarbamol—Leukopenia—Gabapentin—epilepsy syndrome	5.3e-05	0.000731	CcSEcCtD
Methocarbamol—Dizziness—Clonazepam—epilepsy syndrome	5.29e-05	0.00073	CcSEcCtD
Methocarbamol—Nausea—Vigabatrin—epilepsy syndrome	5.29e-05	0.00073	CcSEcCtD
Methocarbamol—Vomiting—Zonisamide—epilepsy syndrome	5.28e-05	0.000729	CcSEcCtD
Methocarbamol—Insomnia—Valproic Acid—epilepsy syndrome	5.27e-05	0.000727	CcSEcCtD
Methocarbamol—Anaphylactic shock—Pregabalin—epilepsy syndrome	5.27e-05	0.000727	CcSEcCtD
Methocarbamol—Dizziness—Phenytoin—epilepsy syndrome	5.26e-05	0.000725	CcSEcCtD
Methocarbamol—Rash—Zonisamide—epilepsy syndrome	5.24e-05	0.000722	CcSEcCtD
Methocarbamol—Dermatitis—Zonisamide—epilepsy syndrome	5.23e-05	0.000722	CcSEcCtD
Methocarbamol—Dizziness—Oxcarbazepine—epilepsy syndrome	5.23e-05	0.000721	CcSEcCtD
Methocarbamol—Nausea—Diazepam—epilepsy syndrome	5.21e-05	0.000718	CcSEcCtD
Methocarbamol—Loss of consciousness—Gabapentin—epilepsy syndrome	5.2e-05	0.000718	CcSEcCtD
Methocarbamol—Headache—Zonisamide—epilepsy syndrome	5.2e-05	0.000718	CcSEcCtD
Methocarbamol—Pruritus—Lamotrigine—epilepsy syndrome	5.19e-05	0.000716	CcSEcCtD
Methocarbamol—Shock—Pregabalin—epilepsy syndrome	5.19e-05	0.000715	CcSEcCtD
Methocarbamol—Somnolence—Valproic Acid—epilepsy syndrome	5.18e-05	0.000715	CcSEcCtD
Methocarbamol—Dyspepsia—Valproic Acid—epilepsy syndrome	5.13e-05	0.000708	CcSEcCtD
Methocarbamol—Convulsion—Gabapentin—epilepsy syndrome	5.13e-05	0.000708	CcSEcCtD
Methocarbamol—Vomiting—Clonazepam—epilepsy syndrome	5.09e-05	0.000702	CcSEcCtD
Methocarbamol—Vomiting—Phenytoin—epilepsy syndrome	5.06e-05	0.000697	CcSEcCtD
Methocarbamol—Rash—Clonazepam—epilepsy syndrome	5.05e-05	0.000696	CcSEcCtD
Methocarbamol—Dermatitis—Clonazepam—epilepsy syndrome	5.04e-05	0.000696	CcSEcCtD
Methocarbamol—Nausea—Felbamate—epilepsy syndrome	5.04e-05	0.000695	CcSEcCtD
Methocarbamol—Vomiting—Oxcarbazepine—epilepsy syndrome	5.03e-05	0.000694	CcSEcCtD
Methocarbamol—Dizziness—Carbamazepine—epilepsy syndrome	5.02e-05	0.000692	CcSEcCtD
Methocarbamol—Headache—Clonazepam—epilepsy syndrome	5.02e-05	0.000692	CcSEcCtD
Methocarbamol—Rash—Phenytoin—epilepsy syndrome	5.01e-05	0.000692	CcSEcCtD
Methocarbamol—Dermatitis—Phenytoin—epilepsy syndrome	5.01e-05	0.000691	CcSEcCtD
Methocarbamol—Rash—Oxcarbazepine—epilepsy syndrome	4.99e-05	0.000688	CcSEcCtD
Methocarbamol—Pain—Valproic Acid—epilepsy syndrome	4.99e-05	0.000688	CcSEcCtD
Methocarbamol—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.98e-05	0.000687	CcSEcCtD
Methocarbamol—Headache—Phenytoin—epilepsy syndrome	4.98e-05	0.000687	CcSEcCtD
Methocarbamol—Headache—Oxcarbazepine—epilepsy syndrome	4.96e-05	0.000684	CcSEcCtD
Methocarbamol—Nausea—Zonisamide—epilepsy syndrome	4.93e-05	0.000681	CcSEcCtD
Methocarbamol—Hypotension—Pregabalin—epilepsy syndrome	4.92e-05	0.000679	CcSEcCtD
Methocarbamol—Dysgeusia—Topiramate—epilepsy syndrome	4.88e-05	0.000673	CcSEcCtD
Methocarbamol—Confusional state—Gabapentin—epilepsy syndrome	4.87e-05	0.000672	CcSEcCtD
Methocarbamol—CA1—Metabolism—UPB1—epilepsy syndrome	4.87e-05	0.00302	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—ATIC—epilepsy syndrome	4.87e-05	0.00302	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—NEU1—epilepsy syndrome	4.87e-05	0.00302	CbGpPWpGaD
Methocarbamol—Dizziness—Lamotrigine—epilepsy syndrome	4.85e-05	0.000669	CcSEcCtD
Methocarbamol—Anaphylactic shock—Gabapentin—epilepsy syndrome	4.83e-05	0.000667	CcSEcCtD
Methocarbamol—Vomiting—Carbamazepine—epilepsy syndrome	4.83e-05	0.000666	CcSEcCtD
Methocarbamol—Feeling abnormal—Valproic Acid—epilepsy syndrome	4.8e-05	0.000663	CcSEcCtD
Methocarbamol—Rash—Carbamazepine—epilepsy syndrome	4.79e-05	0.00066	CcSEcCtD
Methocarbamol—Dermatitis—Carbamazepine—epilepsy syndrome	4.78e-05	0.00066	CcSEcCtD
Methocarbamol—Insomnia—Pregabalin—epilepsy syndrome	4.77e-05	0.000657	CcSEcCtD
Methocarbamol—Nausea—Clonazepam—epilepsy syndrome	4.76e-05	0.000656	CcSEcCtD
Methocarbamol—Headache—Carbamazepine—epilepsy syndrome	4.76e-05	0.000656	CcSEcCtD
Methocarbamol—Shock—Gabapentin—epilepsy syndrome	4.75e-05	0.000656	CcSEcCtD
Methocarbamol—Nausea—Phenytoin—epilepsy syndrome	4.72e-05	0.000652	CcSEcCtD
Methocarbamol—Nausea—Oxcarbazepine—epilepsy syndrome	4.7e-05	0.000648	CcSEcCtD
Methocarbamol—Vision blurred—Topiramate—epilepsy syndrome	4.69e-05	0.000648	CcSEcCtD
Methocarbamol—Somnolence—Pregabalin—epilepsy syndrome	4.69e-05	0.000646	CcSEcCtD
Methocarbamol—CA1—Metabolism—HSD17B4—epilepsy syndrome	4.68e-05	0.0029	CbGpPWpGaD
Methocarbamol—Vomiting—Lamotrigine—epilepsy syndrome	4.66e-05	0.000643	CcSEcCtD
Methocarbamol—Urticaria—Valproic Acid—epilepsy syndrome	4.63e-05	0.000639	CcSEcCtD
Methocarbamol—Rash—Lamotrigine—epilepsy syndrome	4.63e-05	0.000638	CcSEcCtD
Methocarbamol—Dermatitis—Lamotrigine—epilepsy syndrome	4.62e-05	0.000637	CcSEcCtD
Methocarbamol—Body temperature increased—Valproic Acid—epilepsy syndrome	4.61e-05	0.000636	CcSEcCtD
Methocarbamol—Headache—Lamotrigine—epilepsy syndrome	4.6e-05	0.000634	CcSEcCtD
Methocarbamol—CA1—Metabolism—PPP1R3C—epilepsy syndrome	4.52e-05	0.0028	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—GBE1—epilepsy syndrome	4.52e-05	0.0028	CbGpPWpGaD
Methocarbamol—Hypotension—Gabapentin—epilepsy syndrome	4.52e-05	0.000623	CcSEcCtD
Methocarbamol—Nausea—Carbamazepine—epilepsy syndrome	4.51e-05	0.000622	CcSEcCtD
Methocarbamol—Pain—Pregabalin—epilepsy syndrome	4.51e-05	0.000622	CcSEcCtD
Methocarbamol—Vertigo—Topiramate—epilepsy syndrome	4.48e-05	0.000617	CcSEcCtD
Methocarbamol—Syncope—Topiramate—epilepsy syndrome	4.47e-05	0.000616	CcSEcCtD
Methocarbamol—Leukopenia—Topiramate—epilepsy syndrome	4.46e-05	0.000615	CcSEcCtD
Methocarbamol—Loss of consciousness—Topiramate—epilepsy syndrome	4.38e-05	0.000604	CcSEcCtD
Methocarbamol—Insomnia—Gabapentin—epilepsy syndrome	4.37e-05	0.000603	CcSEcCtD
Methocarbamol—Nausea—Lamotrigine—epilepsy syndrome	4.36e-05	0.000601	CcSEcCtD
Methocarbamol—Feeling abnormal—Pregabalin—epilepsy syndrome	4.34e-05	0.000599	CcSEcCtD
Methocarbamol—Convulsion—Topiramate—epilepsy syndrome	4.32e-05	0.000595	CcSEcCtD
Methocarbamol—Somnolence—Gabapentin—epilepsy syndrome	4.3e-05	0.000593	CcSEcCtD
Methocarbamol—Hypersensitivity—Valproic Acid—epilepsy syndrome	4.29e-05	0.000592	CcSEcCtD
Methocarbamol—Dyspepsia—Gabapentin—epilepsy syndrome	4.25e-05	0.000587	CcSEcCtD
Methocarbamol—CA1—Metabolism—ASAH1—epilepsy syndrome	4.25e-05	0.00264	CbGpPWpGaD
Methocarbamol—Urticaria—Pregabalin—epilepsy syndrome	4.19e-05	0.000577	CcSEcCtD
Methocarbamol—Body temperature increased—Pregabalin—epilepsy syndrome	4.17e-05	0.000575	CcSEcCtD
Methocarbamol—CA1—Metabolism—STXBP1—epilepsy syndrome	4.14e-05	0.00256	CbGpPWpGaD
Methocarbamol—Pain—Gabapentin—epilepsy syndrome	4.13e-05	0.00057	CcSEcCtD
Methocarbamol—Pruritus—Valproic Acid—epilepsy syndrome	4.12e-05	0.000569	CcSEcCtD
Methocarbamol—Confusional state—Topiramate—epilepsy syndrome	4.1e-05	0.000565	CcSEcCtD
Methocarbamol—CA1—Metabolism—NT5E—epilepsy syndrome	4.03e-05	0.0025	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—ALAD—epilepsy syndrome	4.03e-05	0.0025	CbGpPWpGaD
Methocarbamol—Shock—Topiramate—epilepsy syndrome	4e-05	0.000552	CcSEcCtD
Methocarbamol—Feeling abnormal—Gabapentin—epilepsy syndrome	3.98e-05	0.000549	CcSEcCtD
Methocarbamol—Hypersensitivity—Pregabalin—epilepsy syndrome	3.88e-05	0.000536	CcSEcCtD
Methocarbamol—Dizziness—Valproic Acid—epilepsy syndrome	3.85e-05	0.000532	CcSEcCtD
Methocarbamol—CA1—Metabolism—ALDH7A1—epilepsy syndrome	3.85e-05	0.00238	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—CACNA1A—epilepsy syndrome	3.85e-05	0.00238	CbGpPWpGaD
Methocarbamol—Urticaria—Gabapentin—epilepsy syndrome	3.84e-05	0.00053	CcSEcCtD
Methocarbamol—Body temperature increased—Gabapentin—epilepsy syndrome	3.82e-05	0.000527	CcSEcCtD
Methocarbamol—Propranolol—CYP2C19—epilepsy syndrome	3.82e-05	0.0196	CrCbGaD
Methocarbamol—Hypotension—Topiramate—epilepsy syndrome	3.8e-05	0.000524	CcSEcCtD
Methocarbamol—CA1—Metabolism—ST3GAL3—epilepsy syndrome	3.76e-05	0.00233	CbGpPWpGaD
Methocarbamol—Pruritus—Pregabalin—epilepsy syndrome	3.73e-05	0.000514	CcSEcCtD
Methocarbamol—Carvedilol—CYP2D6—epilepsy syndrome	3.72e-05	0.0191	CrCbGaD
Methocarbamol—Vomiting—Valproic Acid—epilepsy syndrome	3.71e-05	0.000511	CcSEcCtD
Methocarbamol—CA1—Metabolism—ADSL—epilepsy syndrome	3.69e-05	0.00228	CbGpPWpGaD
Methocarbamol—Insomnia—Topiramate—epilepsy syndrome	3.68e-05	0.000507	CcSEcCtD
Methocarbamol—Rash—Valproic Acid—epilepsy syndrome	3.68e-05	0.000507	CcSEcCtD
Methocarbamol—Dermatitis—Valproic Acid—epilepsy syndrome	3.67e-05	0.000507	CcSEcCtD
Methocarbamol—Headache—Valproic Acid—epilepsy syndrome	3.65e-05	0.000504	CcSEcCtD
Methocarbamol—CA1—Metabolism—GLUL—epilepsy syndrome	3.62e-05	0.00224	CbGpPWpGaD
Methocarbamol—Somnolence—Topiramate—epilepsy syndrome	3.61e-05	0.000499	CcSEcCtD
Methocarbamol—Dyspepsia—Topiramate—epilepsy syndrome	3.58e-05	0.000494	CcSEcCtD
Methocarbamol—Hypersensitivity—Gabapentin—epilepsy syndrome	3.56e-05	0.000491	CcSEcCtD
Methocarbamol—CA1—Metabolism—CACNA1D—epilepsy syndrome	3.55e-05	0.0022	CbGpPWpGaD
Methocarbamol—Dizziness—Pregabalin—epilepsy syndrome	3.49e-05	0.000481	CcSEcCtD
Methocarbamol—Pain—Topiramate—epilepsy syndrome	3.48e-05	0.00048	CcSEcCtD
Methocarbamol—Nausea—Valproic Acid—epilepsy syndrome	3.46e-05	0.000478	CcSEcCtD
Methocarbamol—Pruritus—Gabapentin—epilepsy syndrome	3.42e-05	0.000472	CcSEcCtD
Methocarbamol—Vomiting—Pregabalin—epilepsy syndrome	3.35e-05	0.000462	CcSEcCtD
Methocarbamol—Feeling abnormal—Topiramate—epilepsy syndrome	3.35e-05	0.000462	CcSEcCtD
Methocarbamol—Rash—Pregabalin—epilepsy syndrome	3.32e-05	0.000458	CcSEcCtD
Methocarbamol—CA1—Metabolism—TXNRD1—epilepsy syndrome	3.32e-05	0.00206	CbGpPWpGaD
Methocarbamol—Dermatitis—Pregabalin—epilepsy syndrome	3.32e-05	0.000458	CcSEcCtD
Methocarbamol—Headache—Pregabalin—epilepsy syndrome	3.3e-05	0.000455	CcSEcCtD
Methocarbamol—Urticaria—Topiramate—epilepsy syndrome	3.23e-05	0.000446	CcSEcCtD
Methocarbamol—CA1—Metabolism—AQP1—epilepsy syndrome	3.22e-05	0.002	CbGpPWpGaD
Methocarbamol—Body temperature increased—Topiramate—epilepsy syndrome	3.21e-05	0.000443	CcSEcCtD
Methocarbamol—Dizziness—Gabapentin—epilepsy syndrome	3.2e-05	0.000441	CcSEcCtD
Methocarbamol—Nausea—Pregabalin—epilepsy syndrome	3.13e-05	0.000432	CcSEcCtD
Methocarbamol—Vomiting—Gabapentin—epilepsy syndrome	3.07e-05	0.000424	CcSEcCtD
Methocarbamol—Rash—Gabapentin—epilepsy syndrome	3.05e-05	0.00042	CcSEcCtD
Methocarbamol—Dermatitis—Gabapentin—epilepsy syndrome	3.04e-05	0.00042	CcSEcCtD
Methocarbamol—Headache—Gabapentin—epilepsy syndrome	3.03e-05	0.000418	CcSEcCtD
Methocarbamol—Hypersensitivity—Topiramate—epilepsy syndrome	3e-05	0.000413	CcSEcCtD
Methocarbamol—CA1—Metabolism—CHRM3—epilepsy syndrome	2.91e-05	0.00181	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—KCNJ11—epilepsy syndrome	2.91e-05	0.00181	CbGpPWpGaD
Methocarbamol—Pruritus—Topiramate—epilepsy syndrome	2.88e-05	0.000397	CcSEcCtD
Methocarbamol—Nausea—Gabapentin—epilepsy syndrome	2.87e-05	0.000396	CcSEcCtD
Methocarbamol—Propranolol—CYP2D6—epilepsy syndrome	2.83e-05	0.0146	CrCbGaD
Methocarbamol—Dizziness—Topiramate—epilepsy syndrome	2.69e-05	0.000371	CcSEcCtD
Methocarbamol—Carvedilol—ABCB1—epilepsy syndrome	2.66e-05	0.0137	CrCbGaD
Methocarbamol—Vomiting—Topiramate—epilepsy syndrome	2.59e-05	0.000357	CcSEcCtD
Methocarbamol—Rash—Topiramate—epilepsy syndrome	2.56e-05	0.000354	CcSEcCtD
Methocarbamol—Dermatitis—Topiramate—epilepsy syndrome	2.56e-05	0.000353	CcSEcCtD
Methocarbamol—Headache—Topiramate—epilepsy syndrome	2.55e-05	0.000351	CcSEcCtD
Methocarbamol—Nausea—Topiramate—epilepsy syndrome	2.42e-05	0.000333	CcSEcCtD
Methocarbamol—CA1—Metabolism—ABCG2—epilepsy syndrome	2.38e-05	0.00147	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—CYP2C19—epilepsy syndrome	2.32e-05	0.00143	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—CYP11A1—epilepsy syndrome	2.3e-05	0.00143	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—CYP2D6—epilepsy syndrome	2.08e-05	0.00129	CbGpPWpGaD
Methocarbamol—Propranolol—ABCB1—epilepsy syndrome	2.02e-05	0.0104	CrCbGaD
Methocarbamol—CA1—Metabolism—ADRA2A—epilepsy syndrome	1.98e-05	0.00123	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—BCHE—epilepsy syndrome	1.97e-05	0.00122	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—SLC2A1—epilepsy syndrome	1.88e-05	0.00116	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—PLCB1—epilepsy syndrome	1.86e-05	0.00115	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—TH—epilepsy syndrome	1.85e-05	0.00115	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—HMOX1—epilepsy syndrome	1.54e-05	0.000957	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—CAT—epilepsy syndrome	1.52e-05	0.000945	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—ABCB1—epilepsy syndrome	1.48e-05	0.000919	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—GPX1—epilepsy syndrome	1.38e-05	0.000854	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—AGT—epilepsy syndrome	1.21e-05	0.000749	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—APOE—epilepsy syndrome	1.18e-05	0.000734	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—POMC—epilepsy syndrome	1.02e-05	0.000631	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—ALB—epilepsy syndrome	9.28e-06	0.000575	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—PTGS2—epilepsy syndrome	8.12e-06	0.000503	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—AKT1—epilepsy syndrome	4.08e-06	0.000253	CbGpPWpGaD
